Orthofix International | OFIX - Equity Capital And Reserves


Orthofix International reported $435.19M in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Accuray USD 61.87M 19.3M Sep/2025
AngioDynamics USD 176.33M 2.52M Sep/2025
Artivion USD 448.23M 9.54M Dec/2025
AtriCure USD 491.69M 242K Mar/2026
Dexcom USD 2.96B 210.9M Mar/2026
EDAP TMS EUR 23.32M 4.5M Sep/2025
Globus Medical USD 4.57B 174.42M Dec/2025
Inogen USD 197.18M 2.32M Sep/2025
Insulet USD 1.52B 131.1M Dec/2025
Integra LifeSciences USD 1.04B 1.06M Mar/2026
J&J USD 81.19B 358M Mar/2026
Medtronic USD 48.99B 128M Dec/2025
Mesa Laboratories USD 186.69M 8.22M Dec/2025
Orthofix International USD 435.19M 14.85M Mar/2026
Plus Therapeutics USD 4M 1.06M Dec/2025
Smith & Nephew USD 5.54B 331M Dec/2025
STAAR Surgical USD 344.18M 9.6M Dec/2025
Stryker USD 22.42B 635M Dec/2025
Surmodics USD 111.31M 7.59M Jun/2025
Tandem Diabetes Care USD 155.17M 22.2M Dec/2025
Teleflex USD 3.12B 697.09M Dec/2025
Veracyte USD 1.34B 34.83M Mar/2026
Zimmer Biomet Holdings USD 12.68B 16.1M Mar/2026